• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    72.95 Up 2.65(3.77%) Mar 27, 4:00PM EDT
    |After Hours : 72.95 0.00 (0.00%) Mar 27, 4:33PM EDT
    Add to Portfolio
    Prev Close:70.30
    Open:70.52
    Bid:N/A
    Ask:95.41 x 500
    1y Target Est:89.40
    Beta:1.4
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:70.39 - 73.66
    52wk Range:41.99 - 79.61
    Volume:253,009
    Avg Vol (3m):336,744
    Market Cap:1.43B
    P/E (ttm):130.27
    EPS (ttm):0.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    LGNDUp 3.77%1.43B
    LLYUp 0.19%78.04B
    MRKUp 0.26%163.91B
    RHHBYDown 0.23%N/A

    Key Statistics

    Forward P/E (1 yr):22.04
    P/S (ttm):21.32
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-15) :2.17
    Quarterly EPS Est (Mar-15) :0.27
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):0.76

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback